AMP Capital Investors Ltd cut its stake in shares of Aetna Inc (NYSE:AET) by 6.5% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 160,365 shares of the company’s stock after selling 11,087 shares during the quarter. AMP Capital Investors Ltd’s holdings in Aetna were worth $29,427,000 at the end of the most recent quarter.
Other large investors also recently bought and sold shares of the company. Laurion Capital Management LP purchased a new stake in shares of Aetna in the 2nd quarter worth about $1,299,000. Twin Capital Management Inc. boosted its position in shares of Aetna by 0.5% in the 2nd quarter. Twin Capital Management Inc. now owns 79,540 shares of the company’s stock worth $14,596,000 after buying an additional 390 shares in the last quarter. Glen Harbor Capital Management LLC boosted its position in shares of Aetna by 140.0% in the 2nd quarter. Glen Harbor Capital Management LLC now owns 5,304 shares of the company’s stock worth $973,000 after buying an additional 3,094 shares in the last quarter. CSat Investment Advisory L.P. purchased a new stake in shares of Aetna in the 2nd quarter worth about $162,000. Finally, Scharf Investments LLC purchased a new stake in shares of Aetna in the 2nd quarter worth about $1,440,000. 83.52% of the stock is currently owned by institutional investors and hedge funds.
Several equities research analysts recently commented on AET shares. Zacks Investment Research lowered shares of Aetna from a “hold” rating to a “sell” rating in a research report on Tuesday, July 24th. ValuEngine upgraded shares of Aetna from a “hold” rating to a “buy” rating in a research report on Tuesday, June 26th. Credit Suisse Group decreased their price objective on shares of Aetna from $208.00 to $194.00 and set a “neutral” rating on the stock in a research report on Monday, May 14th. Finally, Cantor Fitzgerald reiterated a “buy” rating and issued a $202.00 price objective on shares of Aetna in a research report on Thursday, August 2nd. Eight research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $200.38.
NYSE:AET opened at $203.08 on Friday. The stock has a market capitalization of $66.34 billion, a price-to-earnings ratio of 19.63, a PEG ratio of 1.74 and a beta of 0.68. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.74 and a current ratio of 0.74. Aetna Inc has a 12-month low of $149.69 and a 12-month high of $203.74.
Aetna (NYSE:AET) last released its earnings results on Thursday, August 2nd. The company reported $3.43 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $3.04 by $0.39. The company had revenue of $15.56 billion for the quarter, compared to analyst estimates of $15.59 billion. Aetna had a net margin of 5.77% and a return on equity of 20.66%. The firm’s quarterly revenue was up .2% on a year-over-year basis. During the same period in the prior year, the firm earned $3.42 EPS. analysts forecast that Aetna Inc will post 11.31 earnings per share for the current year.
Aetna Company Profile
Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.